Verona Pharma Plc ADR (NASDAQ: VRNA) Is Currently 1.22 Percent Above Its 52-Week High, But It Still Offers Strong Upside Potential.
Verona Pharma Plc ADR (NASDAQ:VRNA)’s traded shares stood at 0.48 million during the latest session, with the company’s beta value hitting 0.45. At the last